BRAC Bank earned Tk 1,432 crore in FY2024. Eastern Bank PLC earned Tk 660 crore — less than half. Yet EBL delivered a higher return on equity: 15.4% versus BRAC Bank’s 14.2%. The smaller bank squeezed more profit from every taka its shareholders invested.
That single comparison tells you why ROE matters more than raw earnings. And it tells you almost nothing — until you understand what drives the number.
The Formula Is Simple. The Interpretation Is Not.
Return on Equity equals net income divided by shareholders’ equity, expressed as a percentage:
ROE = Net Income / Shareholders’ Equity x 100
BRAC Bank’s calculation: Tk 1,432 crore net income / Tk 10,057 crore shareholders’ equity = 14.2%.
The formula answers one question: for every taka shareholders have invested in this company, how many paisa did management generate in profit? A 14.2% ROE means BRAC Bank produced Tk 14.20 in profit for every Tk 100 of shareholder equity.
Simple enough. But here is where most investors stop — and where the real analysis begins. Because two companies can report identical ROEs for completely different reasons, and one of those reasons should worry you.
What DuPont Analysis Reveals About the Number
ROE is actually three forces multiplied together:
ROE = Net Profit Margin x Asset Turnover x Financial Leverage
Net profit margin measures operational efficiency — how much of each taka in revenue survives as profit. Asset turnover measures how hard the company works its assets to generate sales. Financial leverage measures how much debt amplifies the returns.
This decomposition matters because it exposes the source of returns. A pharma company earning 14.6% ROE through high profit margins and low debt is a fundamentally different proposition from a bank earning 14.2% ROE through massive leverage on thin margins. Both numbers look nearly identical. The risk profiles could not be more different.
Bangladesh banks typically carry ROA (return on total assets) of just 1-2%, yet they deliver ROE of 12-18%. The difference is leverage — banks operate with far more borrowed money relative to equity than manufacturers do. That leverage amplifies returns on the way up and amplifies losses on the way down.
Four DSE Stocks, Two Sectors, One Metric
Consider these FY2024 numbers side by side:
| Company | Sector | ROE | EPS | P/E | Dividend Yield |
|---|---|---|---|---|---|
| EBL | Banking | 15.4% | Tk 4.86 | 5.53 | 7.09% |
| BRAC Bank | Banking | 14.2% | Tk 6.95 | 10.83 | 2.55% |
| Square Pharma | Pharma | 14.6% | Tk 23.61 | 8.04 | 5.74% |
| Beximco Pharma | Pharma | 11.3% | Tk 13.07 | 9.01 | 3.39% |
EBL’s higher ROE comes from efficient cost management and strong fee income — genuine operational advantages. BRAC Bank’s slightly lower number reflects a broader asset base from its SME lending expansion, which may generate higher returns in future years but dilutes current ROE.
In pharma, Square Pharma’s 14.6% ROE reflects market leadership, the strongest distribution network in Bangladesh, and minimal debt. Beximco Pharma’s 11.3% is respectable but lower — despite exporting to 55+ countries. The export model requires more capital tied up in logistics, regulatory approvals, and working capital across markets.
Notice something critical: the banking sector benchmark for ROE is 12-18%, while pharma runs 10-15%. Comparing BRAC Bank’s 14.2% to Square Pharma’s 14.6% and concluding they are equally efficient is a mistake. BRAC Bank’s number is average for its sector. Square Pharma’s is near the top of its sector. Context changes everything.
The Red Flags That ROE Cannot Hide
A high ROE is not automatically good news. Four warning signs demand investigation:
Sudden spikes. If a company’s ROE jumps from 8% to 22% in one year, check whether net income includes one-time asset sales or accounting adjustments. Sustainable ROE moves gradually.
High ROE with high debt. A debt-to-equity ratio above 2.0 paired with an impressive ROE means leverage is doing the heavy lifting. When credit conditions tighten — as they did across Bangladesh’s banking sector in 2023 — those amplified returns can reverse sharply.
Declining trends. A company reporting 18% ROE five years ago and 11% today is deploying capital less efficiently over time. Management may be struggling to find profitable uses for retained earnings.
Negative equity. If a company’s liabilities exceed its assets, shareholders’ equity turns negative — and ROE becomes mathematically meaningless. Several Z-category DSE stocks fall into this category.
How to Actually Use This Number
ROE is most powerful when combined with other metrics. A stock trading below its net asset value with a consistent ROE above 12% over five years is signalling potential undervaluation — the market is pricing the company below the book value of assets that are generating solid returns.
Pair ROE with the P/E ratio for a fuller picture. High ROE plus low P/E can indicate a value opportunity. High ROE plus high P/E means the market has already priced in that efficiency.
The most reliable ROE signal on the DSE is consistency. A company that delivers 13-15% year after year is almost always a better investment than one that swings between 5% and 25%. Consistency means management knows how to deploy capital. Volatility means they are guessing — and so are you.